TGF-Beta-Activated Cancer-Associated Fibroblasts Limit Cetuximab Efficacy in Preclinical Models of Head and Neck Cancer

por Yegodayev, Ksenia M., Novoplansky, Ofra, Golden, Artemiy, Prasad, Manu, Levin, Liron, Jagadeeshan, Sankar, Zorea, Jonathan, Dimitstein, Orr, Joshua, Ben-Zion, Cohen, Limor, Khrameeva, Ekaterina, Elkabets, Moshe
Publicado 2020

Tumor Tissue Explant Culture of Patient-Derived Xenograft as Potential Prioritization Tool for Targeted Therapy

por Ghosh, Susmita, Prasad, Manu, Kundu, Kiran, Cohen, Limor, Yegodayev, Ksenia M., Zorea, Jonathan, Joshua, Ben-Zion, Lasry, Batel, Dimitstein, Orr, Bahat-Dinur, Anat, Mizrachi, Aviram, Lazar, Vladimir, Elkabets, Moshe, Porgador, Angel
Publicado 2019

IGF2 Mediates Resistance to Isoform-Selective-Inhibitors of the PI3K in HPV Positive Head and Neck Cancer

por Badarni, Mai, Prasad, Manu, Golden, Artemiy, Bhattacharya, Baisali, Levin, Liron, Yegodayev, Ksenia M., Dimitstein, Orr, Joshua, Ben-Zion, Cohen, Limor, Khrameeva, Ekaterina, Kong, Dexin, Porgador, Angel, Braiman, Alex, Grandis, Jennifer R., Rotblat, Barak, Elkabets, Moshe
Publicado 2021

MEK1/2 inhibition transiently alters the tumor immune microenvironment to enhance immunotherapy efficacy against head and neck cancer

por Prasad, Manu, Zorea, Jonathan, Jagadeeshan, Sankar, Shnerb, Avital B, Mathukkada, Sooraj, Bouaoud, Jebrane, Michon, Lucas, Novoplansky, Ofra, Badarni, Mai, Cohen, Limor, Yegodayev, Ksenia M, Tzadok, Sapir, Rotblat, Barak, Brezina, Libor, Mock, Andreas, Karabajakian, Andy, Fayette, Jérôme, Cohen, Idan, Cooks, Tomer, Allon, Irit, Dimitstein, Orr, Joshua, Benzion, Kong, Dexin, Voronov, Elena, Scaltriti, Maurizio, Carmi, Yaron, Conde-Lopez, Cristina, Hess, Jochen, Kurth, Ina, Morris, Luc G T, Saintigny, Pierre, Elkabets, Moshe
Publicado 2022